Epicrispr Biotechnologies Announces FDA Clearance of IND Application for EPI-321, A First-in-Class Epigenetic Therapy for ...

The vector includes a cytomegalovirus (CMV ... In January 2025, Beacon Therapeutics Holdings Limited reported that the FDA ...

Several companies will head to the FDA seeking approval of new Duchenne muscular dystrophy treatments next year but the death ...

The phase 3 trial design evaluating IMNN-001 in newly diagnosed advanced ovarian cancer has been finalized among regulatory ...

The death of a 16-year-old boy taking a gene therapy this month dealt a fresh blow to the Duchenne muscular dystrophy ...

Hemogenyx Pharmaceuticals Files Annual IND Report with FDA for HG-CT-1 CAR-T Therapy for AML LONDON, UK / ACCESS Newswire / April 3, 2025 / Hemogenyx Pharmaceuticals plc (LSE:HEMO) is pleased to annou ...

Toxicity related to the systematic delivery of IL-12, a well-known and widely researched anti-tumor cytokine, has limited its ...

Cell And Gene Therapy Market Size and ForecastThe global cell and gene therapy market is projected to witness significant ...

Low doses of a drug already approved for treating rare genetic conditions in humans kills mosquitoes dead. Scientists say it ...

Businesses can expect significant efficiency gains with AI’s ability to streamline processes, enhance decision-making and ...